A team of scientists has found that an existing cancer drug could be repurposed to target a subset of cancers that currently lack targeted treatment options and is often associated with poor outcomes. This subset of cancers makes up 15 per cent of all cancers and is especially prevalent in aggressive tumors such as osteosarcoma (bone tumor) and glioblastoma (brain tumor).
Click here for original story, Existing cancer drug could be repurposed to fight certain aggressive cancers
Source: ScienceDaily